Cargando…

Angiotensin‐converting enzyme 2 as a versatile player in the management of coronavirus disease 2019

Detalles Bibliográficos
Autor principal:	Amano, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405104/ https://www.ncbi.nlm.nih.gov/pubmed/32657484 http://dx.doi.org/10.1111/jdi.13346

Ejemplares similares

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019
por: Suh, Sang Heon, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
por: Lambert, Daniel W., et al.
Publicado: (2008)

Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System
por: Edmonston, Daniel L., et al.
Publicado: (2020)

Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms
por: Xu, Baohui, et al.
Publicado: (2021)

The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019
por: Zhu, Zhe, et al.
Publicado: (2020)

The role and significance of angiotensin‐converting enzyme 2 peptides in the treatment of coronavirus disease 2019
por: Liu, Yang, et al.
Publicado: (2021)

Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
por: Ferri, Claudio, et al.
Publicado: (2021)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Rossato, Marco, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
por: Gupta, Nitesh, et al.
Publicado: (2020)

Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
por: Liu, Meng-Yuan, et al.
Publicado: (2020)

Angiotensin converting enzyme defects in shock: implications for future therapy
por: Chawla, Lakhmir S., et al.
Publicado: (2018)

On the essentiality of the angiotensin converting enzyme 2 receptor for SARS‐CoV‐2 infection and the potential of soluble angiotensin converting enzyme 2 proteins as universal approach for variants causing COVID‐19
por: Hassler, Luise, et al.
Publicado: (2022)

Potential use of the S-protein–Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019
por: Feng, Long, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019
por: Zheng, Haoyi, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2)
por: Zemlin, Annalise E, et al.
Publicado: (2020)

Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children?
por: Eun, Lucy Youngmin
Publicado: (2021)

Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
por: Khalili, Azadeh, et al.
Publicado: (2021)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Komiyama, Maki, et al.
Publicado: (2020)

Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019
por: Oddy, Christopher, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence
por: Hennessy, Sean, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
por: Sommerstein, Rami, et al.
Publicado: (2020)

Angiotensin‐converting enzyme 2 (ACE2), SARS‐CoV‐2 and the pathophysiology of coronavirus disease 2019 (COVID‐19)
por: Bourgonje, Arno R, et al.
Publicado: (2020)

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
por: Li, Wenhui, et al.
Publicado: (2003)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
por: Leowattana, Wattana
Publicado: (2021)

The Cell Biology of the SARS Coronavirus Receptor, Angiotensin-Converting Enzyme 2
por: Lambert, Daniel W.
Publicado: (2009)

Angiotensin-converting enzyme 2 in lung diseases
por: Kuba, Keiji, et al.
Publicado: (2006)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

The therapeutic potential of the novel angiotensin-converting enzyme 2 in the treatment of coronavirus disease-19
por: Oyagbemi, Ademola Adetokunbo, et al.
Publicado: (2021)

Is there any relationship between serum zinc levels and angiotensin-converting enzyme 2 gene expression in patients with coronavirus disease 2019?
por: Bagheri-Hosseinabadi, Zahra, et al.
Publicado: (2022)

Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
por: MITANI, Sawane, et al.
Publicado: (2013)

Angiotensin-Converting Enzyme 2-Based Biosensing Modalities and Devices for Coronavirus Detection
por: Gul, Ijaz, et al.
Publicado: (2022)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Proposal for Coronavirus Disease 2019 Management
por: Downs, John B., et al.
Publicado: (2020)

Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor
por: Hameed, Noor S., et al.
Publicado: (2023)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a45d1dp5nruqikdt36md9bo278